BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 30454050)

  • 21. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
    van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
    BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
    Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small airway function measured using forced expiratory flow between 25% and 75% of vital capacity and its relationship to airflow limitation in symptomatic ever-smokers: a cross-sectional study.
    Alobaidi NY; Almeshari M; Stockley J; Stockley RA; Sapey E
    BMJ Open Respir Res; 2022 Oct; 9(1):. PubMed ID: 36202407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.
    Dilektasli AG; Porszasz J; Casaburi R; Stringer WW; Bhatt SP; Pak Y; Rossiter HB; Washko G; Castaldi PJ; Estepar RSJ; Hansen JE;
    Chest; 2016 Nov; 150(5):1080-1090. PubMed ID: 27452770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV
    Saint-Pierre M; Ladha J; Berton DC; Reimao G; Castelli G; Marillier M; Bernard AC; O'Donnell DE; Neder JA
    Chest; 2019 Sep; 156(3):497-506. PubMed ID: 30768928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway tree caliber heterogeneity and airflow obstruction among older adults.
    Vameghestahbanati M; Kingdom L; Hoffman EA; Kirby M; Allen NB; Angelini E; Bertoni A; Hamid Q; Hogg JC; Jacobs DR; Laine A; Maltais F; Michos ED; Sack C; Sin D; Watson KE; Wysoczanksi A; Couper D; Cooper C; Han M; Woodruff P; Tan WC; Bourbeau J; Barr RG; Smith BM;
    J Appl Physiol (1985); 2024 May; 136(5):1144-1156. PubMed ID: 38420676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
    Bhatt SP; Balte PP; Schwartz JE; Cassano PA; Couper D; Jacobs DR; Kalhan R; O'Connor GT; Yende S; Sanders JL; Umans JG; Dransfield MT; Chaves PH; White WB; Oelsner EC
    JAMA; 2019 Jun; 321(24):2438-2447. PubMed ID: 31237643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spirometric impairments in long-term insulators. Relationships to duration of exposure, smoking, and radiographic abnormalities.
    Miller A; Lilis R; Godbold J; Chan E; Wu X; Selikoff IJ
    Chest; 1994 Jan; 105(1):175-82. PubMed ID: 8275729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and Radiologic Disease in Smokers With Normal Spirometry.
    Regan EA; Lynch DA; Curran-Everett D; Curtis JL; Austin JH; Grenier PA; Kauczor HU; Bailey WC; DeMeo DL; Casaburi RH; Friedman P; Van Beek EJ; Hokanson JE; Bowler RP; Beaty TH; Washko GR; Han MK; Kim V; Kim SS; Yagihashi K; Washington L; McEvoy CE; Tanner C; Mannino DM; Make BJ; Silverman EK; Crapo JD;
    JAMA Intern Med; 2015 Sep; 175(9):1539-49. PubMed ID: 26098755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicted lower limit of normal reduces misclassification risk of airflow limitation in asymptomatic elderly never-smokers.
    Wang Y; Xiao W; Ma DD; Jiang YY
    Chin Med J (Engl); 2013; 126(18):3486-92. PubMed ID: 24034095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study.
    Lenoir A; Fitting JW; Marques-Vidal PM; Vollenweider P; Nicod LP
    Respir Res; 2018 Dec; 19(1):250. PubMed ID: 30545344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and 1-year outcomes of variable obstruction in participants with preserved spirometry: results from the ECOPD study in China.
    Wu F; Li H; Deng Z; Yang H; Zheng Y; Zhao N; Dai C; Peng J; Lu L; Wang Z; Wen X; Xiao S; Zhou K; Wu X; Tang G; Wan Q; Sun R; Cui J; Yang C; Chen S; Huang J; Yu S; Zhou Y; Ran P
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38789282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.
    Wan ES; Hokanson JE; Murphy JR; Regan EA; Make BJ; Lynch DA; Crapo JD; Silverman EK;
    Am J Respir Crit Care Med; 2011 Jul; 184(1):57-63. PubMed ID: 21493737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
    Woodruff PG; Barr RG; Bleecker E; Christenson SA; Couper D; Curtis JL; Gouskova NA; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Lazarus SC; Martinez FJ; Paine R; Rennard S; Tashkin DP; Han MK;
    N Engl J Med; 2016 May; 374(19):1811-21. PubMed ID: 27168432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.